COVID-19 Vaccines and Vaccination Report: The Nigeria Perspective

COVID-19 vaccine like other vaccines is developed to produce acquired immunity against the virus which causes coronavirus disease. The spread of led quick study by various science laboratories all over world on preventive role and mortality rate reduction potential covid vaccines. Celebration has been witnessed in different part for played cases arising from infection. This review focused adverse event with perspective Nigerian populace. type approved use WHO include; viral vector Oxford-Astrazenca its class, RNA vaccines, whole (having Sinopharm, Sinovac it class), protein subunit (with Novavax (ESI, 2021), EpiVacCorona class). In Nigeria, about 8,439 mild reactions have reported National Health Care Development Agency (NPHCDA), following administration first doses Oxford-AstraZeneca vaccine. report showed that out a million persons who received vaccine, effects, while 52 suffered moderate severe events receiving jab. Generally, proven be effective combating limiting infection covid-19 among citizenry.